Citations as recorded by:

1. The effect of CYP3A5 genetic polymorphisms on adverse events in patients with ulcerative colitis treated with tacrolimus

Digestive and Liver Disease, 2017, 49(1) p. 24

DOI: 10.1016/j.dld.2016.09.008

Citations as recorded by: Cross Ref Google

2. Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes

Pharmacogenomics, 2017, 18(2) p. 165

DOI: 10.2217/pgs-2016-0146

Citations as recorded by: Cross Ref

3. Efficacy and safety of tacrolimus in systemic lupus erythematosus patients with refractory thrombocytopenia: a retrospective study

Lupus,

DOI: 10.1177/0961203317711011

Citations as recorded by: Cross Ref Google

4. Analysis of common polymorphisms within NR1I2 and NR1I3 genes and tacrolimus dose-adjusted concentration in stable kidney transplant recipients

Year: 2017

Citations as recorded by: Google

5. Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.

Ther Drug Monit, 2016, 38 Suppl 1 p. S

DOI: 1

Citations as recorded by: Google

6. Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs

Therapeutic Drug Monitoring, 2016, 38 p. S57

DOI: 10.1097/FTD.0000000000000255

Citations as recorded by: Google

7. Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing toCYP3A5Genotype

Am J Transplant, 2016, 16(9) p. 2670

DOI: 10.1111/ajt.13788

Citations as recorded by: Cross Ref

8. Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients

Year: 2016

Citations as recorded by: Google

9. Making Every Drop Count for Pediatric Kidney Transplant Patients

Hospital Pediatrics, 2015, 5(5) p. 287

DOI: 10.1542/hpeds.2014-0146

Citations as recorded by: Google

10. ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis

Clinica Chimica Acta, 2015, 445 p. 79

DOI: 10.1016/j.cca.2015.03.021

Citations as recorded by: Cross Ref Google

11. A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cells

Drug Discovery Today, 2015, 20(1) p. 37

DOI: 10.1016/j.drudis.2014.10.011

Citations as recorded by: Cross Ref Google

12. Effect of CYP3A5* 3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

Year: 2015

Citations as recorded by: Google

13. Which genetic determinants should be considered for tacrolimus dose optimization in kidney transplantation? A combined analysis of genes affecting the CYP3A locus

Year: 2015

Citations as recorded by: Google

14. Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of tacrolimus in Chinese adult liver transplant patients

Year: 2015

Citations as recorded by: Google

15. Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Citation …

Year: 2015

Citations as recorded by: Google

16. Urinary Neutrophil Gelatinase-Associated Lipocalin: A Useful Biomarker for Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients

PLoS ONE, 2014, 9(10) p. e110527

DOI: 10.1371/journal.pone.0110527

Citations as recorded by: Cross Ref Google

17. Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation

PLoS ONE, 2014, 9(10) p. e109464

DOI: 10.1371/journal.pone.0109464

Citations as recorded by: Cross Ref Google

18. TT Genotype of Transforming Growth Factor Beta1 +869C/T Is Associated With the Development of Chronic Kidney Disease After Liver Transplantation

Transplantation Proceedings, 2014, 46(9) p. 3108

DOI: 10.1016/j.transproceed.2014.10.002

Citations as recorded by: Cross Ref

19. Hypertension and Hepatitis C Virus Infection Are Strong Risk Factors for Developing Late Renal Dysfunction After Living Donor Liver Transplantation: Significance of Renal Biopsy

Transplantation Proceedings, 2014, 46(3) p. 804

DOI: 10.1016/j.transproceed.2013.11.103

Citations as recorded by: Cross Ref

20. CYP3A5genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients

Pediatr Transplantation, 2014, 18(2) p. 166

DOI: 10.1111/petr.12216

Citations as recorded by: Cross Ref

21. Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal …

Year: 2014

Citations as recorded by: Google

22. TT genotype of transforming growth factor beta1+ 869C/T is associated with the development of chronic kidney disease after liver transplantation

Year: 2014

Citations as recorded by: Google

23. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: A meta-analysis

Gene, 2013, 531(2) p. 476

DOI: 10.1016/j.gene.2013.09.024

Citations as recorded by: Cross Ref Google

24. Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms

J Clin Pharm Ther, 2013, 38(4) p. 333

DOI: 10.1111/jcpt.12066

Citations as recorded by: Cross Ref Google

25. Kch1 Family Proteins Mediate Essential Responses to Endoplasmic Reticulum Stresses in the YeastsSaccharomyces cerevisiaeandCandida albicans

J. Biol. Chem., 2013, 288(48) p. 34861

DOI: 10.1074/jbc.M113.508705

Citations as recorded by: Cross Ref

26. Maintenance immunosuppression in renal transplantation

Current Opinion in Pharmacology, 2013, 13(4) p. 662

DOI: 10.1016/j.coph.2013.05.004

Citations as recorded by: Cross Ref Google

27. 细胞色素 P4503A 亚家族多肽 5 基因多态性对肾移植患者术后他克莫司血药浓度的影响

Year: 2013

Citations as recorded by: Google

28. Personalización del tratamiento inmunosupresor con tacrolimo en pacientes con trasplante renal

Year: 2013

Citations as recorded by: Google

29. Sammenheng mellom urinsyre og inflammasjon og vaskulær funksjon hos nyretransplanterte pasienter

Year: 2013

Citations as recorded by: Google